Search Page
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1946 | 1 |
1949 | 1 |
1950 | 3 |
1951 | 1 |
1952 | 2 |
1953 | 1 |
1954 | 1 |
1956 | 1 |
1960 | 1 |
1961 | 1 |
1962 | 2 |
1963 | 2 |
1964 | 4 |
1965 | 2 |
1966 | 2 |
1968 | 3 |
1969 | 3 |
1971 | 4 |
1972 | 4 |
1973 | 2 |
1974 | 2 |
1975 | 4 |
1976 | 10 |
1977 | 12 |
1978 | 4 |
1979 | 5 |
1980 | 9 |
1981 | 10 |
1982 | 9 |
1983 | 9 |
1984 | 5 |
1985 | 15 |
1986 | 11 |
1987 | 10 |
1988 | 10 |
1989 | 7 |
1990 | 13 |
1991 | 9 |
1992 | 9 |
1993 | 13 |
1994 | 12 |
1995 | 9 |
1996 | 3 |
1997 | 15 |
1998 | 10 |
1999 | 12 |
2000 | 18 |
2001 | 10 |
2002 | 8 |
2003 | 11 |
2004 | 14 |
2005 | 4 |
2006 | 9 |
2007 | 7 |
2008 | 8 |
2009 | 13 |
2010 | 15 |
2011 | 15 |
2012 | 15 |
2013 | 15 |
2014 | 15 |
2015 | 23 |
2016 | 15 |
2017 | 14 |
2018 | 14 |
2019 | 21 |
2020 | 16 |
2021 | 17 |
2022 | 16 |
2023 | 2 |
Search Results
Compared with the L-norvaline or doxorubicin hydrochloride (DOX) group, the proliferation abilities of 4 T1 cells were the lowest in the L-norvaline combined with DOX (p < 0.05). ...L-norvaline combined with DOX could clearly inhibit the proliferation acti
…RESULTS: Treatment of HFD/STZ mice with L-norvaline and L-arginine reduced fasting blood glucose levels by 27.1% vs. untreated HFD/STZ rats (p < 0.001). Blood levels of total cholesterol, low-density lipoprotein (LDL), and malondialdehyde (MDA), a marker for oxidative s
…